Squarepoint Ops LLC Lowers Stake in Phreesia, Inc. (NYSE:PHR)

Squarepoint Ops LLC decreased its stake in Phreesia, Inc. (NYSE:PHR - Free Report) by 85.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 22,230 shares of the company's stock after selling 127,424 shares during the quarter. Squarepoint Ops LLC's holdings in Phreesia were worth $559,000 as of its most recent SEC filing.

Several other hedge funds have also recently modified their holdings of PHR. Barclays PLC lifted its position in shares of Phreesia by 83.6% during the third quarter. Barclays PLC now owns 94,929 shares of the company's stock worth $2,163,000 after purchasing an additional 43,225 shares in the last quarter. R Squared Ltd acquired a new stake in shares of Phreesia in the fourth quarter valued at $30,000. Rhumbline Advisers grew its stake in Phreesia by 7.4% during the 4th quarter. Rhumbline Advisers now owns 83,631 shares of the company's stock worth $2,104,000 after purchasing an additional 5,756 shares in the last quarter. Venturi Wealth Management LLC acquired a new stake in Phreesia in the 4th quarter valued at about $76,000. Finally, Peregrine Capital Management LLC boosted its stake in shares of Phreesia by 0.8% in the 4th quarter. Peregrine Capital Management LLC now owns 319,327 shares of the company's stock valued at $8,034,000 after buying an additional 2,531 shares during the period. Institutional investors and hedge funds own 92.10% of the company's stock.

Analyst Ratings Changes

A number of research analysts have recently commented on the company. KeyCorp dropped their price objective on Phreesia from $30.00 to $28.00 and set an "overweight" rating on the stock in a report on Wednesday, April 16th. Citigroup reaffirmed a "buy" rating on shares of Phreesia in a research note on Wednesday, May 28th. DA Davidson lowered their target price on Phreesia from $36.00 to $34.00 and set a "buy" rating on the stock in a research note on Monday, April 14th. Truist Financial increased their price target on Phreesia from $34.00 to $35.00 and gave the stock a "buy" rating in a report on Thursday, May 29th. Finally, Needham & Company LLC reissued a "buy" rating and issued a $29.00 price objective on shares of Phreesia in a research note on Thursday, March 13th. Twelve research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the company currently has a consensus rating of "Buy" and an average target price of $31.64.

Insider Buying and Selling

In related news, CFO Balaji Gandhi sold 8,045 shares of the company's stock in a transaction that occurred on Tuesday, April 8th. The stock was sold at an average price of $23.85, for a total value of $191,873.25. Following the sale, the chief financial officer now owns 108,411 shares of the company's stock, valued at approximately $2,585,602.35. This represents a 6.91% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, General Counsel Allison C. Hoffman sold 3,496 shares of the firm's stock in a transaction on Monday, March 17th. The stock was sold at an average price of $25.32, for a total value of $88,518.72. Following the transaction, the general counsel now directly owns 139,134 shares of the company's stock, valued at $3,522,872.88. The trade was a 2.45% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 42,474 shares of company stock worth $1,023,208 in the last three months. Corporate insiders own 5.50% of the company's stock.

Phreesia Price Performance

Shares of PHR traded up $0.93 on Friday, reaching $26.71. The stock had a trading volume of 171,072 shares, compared to its average volume of 438,450. Phreesia, Inc. has a twelve month low of $17.07 and a twelve month high of $30.53. The firm has a market capitalization of $1.59 billion, a PE ratio of -18.18 and a beta of 0.74. The firm has a 50-day moving average of $24.72 and a 200 day moving average of $25.41. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.04.

Phreesia (NYSE:PHR - Get Free Report) last posted its earnings results on Wednesday, May 28th. The company reported ($0.07) EPS for the quarter, topping analysts' consensus estimates of ($0.13) by $0.06. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The company had revenue of $115.94 million for the quarter, compared to the consensus estimate of $115.00 million. During the same period in the previous year, the business earned ($0.05) earnings per share. Phreesia's quarterly revenue was up 14.5% compared to the same quarter last year. Sell-side analysts expect that Phreesia, Inc. will post -1.1 EPS for the current year.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.